Pediatric Hematology/Oncology
Questions discussed in this category
Specifically, headaches thought not to be related to increased ICP.
Is there a target IgG level to aim for?
What should hematologists be aware of in monitoring these patients?
If so, how long do you continue medication and when do you discontinue? Does treatment with surgical resection versus radiation alone change your mana...
Is there a role for nelarabine and venetoclax in this setting?
Do you discuss the risk of sickle cell crises with G-CSF? What about for patients with sickle cell trait?
My patient’s family has asked that I don’t tell her that she has metastatic cancer because it will devastate her. I am planning on palliat...
How do you advise patients who strongly desire chemotherapy?
Is there a role for non-myeloablative regimens?
Chemotherapy is associated with acquiring C diff colitis. Does immunotherapy share that same risk and necessitate ruling out infection prior to anti-d...
Would you offer radiation and chemotherapy, vorasidenib, or observation?
No clear inciting etiology found.
Would you consider dexamethasone +/- cytokine blockade (IL-1, IL-6, or IFN-g)? What do you think about the data for...
Given nationwide shortage in vinblastine, several of my patients under active therapy are facing delays in their therapies. Is it appropriate to subst...
Do you do additional workup for venous obstruction or any other different testing/evaluation?
Do social or economic factors (i.e., relative cost of acquiring LMWH, the patient being injection averse) affect your decision to use DOACs?
Do you s...
I've seen a handful of fatal radiation pneumonitis associated with rapid steroid tapers by the non-treating physicians. How do you recommend prescribi...
How would your recommendation change if the patient has H63 homozygous mutation?
Do you treat this similarly to IDH-Wildtype GBM with the STUPP regimen? Is there any role of less-intensive paradigms, such as 59.4 Gy/33 fx?
How do we approach patients with rare tumors given the paucity of data?
There was a recall on viscous lidocaine and many of our patients cannot find it. What would you recommend as alternatives?
Do you insist on ambulatory/home blood pressures to rule in/out white coat hypertension? Does your practice have a system to log patients' BPs to supp...
What criteria do you use to define steroid-refractory disease?
Does your management different by organ system involved - GI vs skin vs other?
Are there other measures, pharmocologic or adjunctive, that can be used or are under investigation to mitigate cardiotoxicity related to chemo- or rad...
The patient presented with a numb chin, more to the right of his face; an MRI did report mandibular nerve opacity, which is non-specific per neuro-rad...
How do you choose between RIC compared to MAC? Is there evidence for one over the other in an otherwise healthy, young patient?
Do you include hypome...
NCCN says "consider autologous HCT" while retrospective data seems to support SCT in most histologies like AITL
Have you changed your practice given BMT-CTN 1506/Morpho results?
Would you utilize maintenance therapy in patients who achieve MRD- remission?
Do you recommend adjuvant chemotherapy after radiation treatment?
Would you consider stopping therapy versus doxorubicin + dacarbazine/doxorubicin alone versus alternative chemotherapy ?
Have you been able to deliver standard of care treatment?
At the time of count recovery or do you continue it throughout induction and consolidation?
The patient was recently diagnosed with pre-B ALL and is on day 10 of CALGB 10403. He is expectedly neutropenic as he received daunorubicin and vincri...
Is completing nodal dissection warranted for surgical management?
There are various formulations of intravenous iron; each with varying costs, test dose requirement, elemental dose, and number or time of infusions ne...
While follow up ultrasound is not usually recommended in provoked DVT, it often is done either for other reasons or by other physicians. Would this in...
How do you counsel patients and caregivers? Do you prescribe medications (''appetite stimulants'') with the goal to improve appetite even if they do n...
For instance, do you factor availability of RNAseq, inclusion of normal blood controls, and QNS rates into your decision?
Or offer resection followed by adjuvant therapy?
Practice varies among oncologists and institutions
Specifically, asymptomatic subsegmental PE diagnosed within a month from planned bilateral mastectomy for breast cancer.
What workup do you typically recommend?
Would you test for bone marrow failure syndromes before beginning the conditioning regimen?
Is it necessary to delay the start of radiation therapy for males planning on sperm banking for fertility preservation?
Would a negative NGS eliminate the possibility of MDS?
Is bone marrow biopsy indicated in a patient with pancytopenia with a negative NGS panel?
Is this an artifact of what agent prior clinical trials used or something to do with the mechanism of action (i.e., less mineralocorticoid effect of d...
Such as the case in which a patient is unresponsive to steroids, IVIG, TPO-agonist, rituximab, splenectomy, and even fostamitinib.
Do you re-challenge them? If so, what pre-medications do you give? Do you dose reduce the cytarabine? Or do you switch another regimen?
Would you consider low dose indefinite anticoagulation in any scenario? Any difference in approach between hematological malignancy and solid tum...
How is this entity distinct from other secondary HLH entities?
Patient initially achieved CR with VAC-IE with resolution of presumed lung mets and 100% necrosis in LLE primary tumor on BKA. Then was NED again afte...
Bleomycin omitted due to asymptomatic decline in DLCO
Please specify how your institution is allocating resources now or will be soon.
(i.e. frequency of serial BNP, troponin, cMRI)
Presuming there are no matched unrelated donors.
Would you give a trial of IST first or immediately refer for SCT if the patient has matched siblings?
How do you "have the talk" in a way that is straightforward without emotionally crushing the patient?
Is your approach different than that to a primary essential tremor?
What would you want community oncologists to know when following these patients? Are there any other special issues to follow especially in AYA?
How can these interactions be improved?
There is evidence that parents do not adequately understand the purpose of phase I pediatric cancer trials (Cousino et al., PMID 23071225).
If so, what platelet count threshold would you use? Would age impact your decision? Would you do a bone marrow to rule out primary MPD in adults if th...
For patients not on study, would you consider replacing missed doses of peg with a non-asparaginase based chemotherapy?
There are conflicting reports whether it contributes to renal insufficiency. If you do switch, what is your preferred TKI in this scenario?
If so, how often do you check these labs?
How is your approach different from or similar to those who undergo surgical menopause?
What are indications to order gene mutation studies (e.g. ELANE) and how would it help the patient?
What would you recommend within the first year after ATG and thereafter if still maintained on cyclosporine?
What would be your next treatment for a young adult patient with medulloblastoma refractory to repeat resection, craniospinal irradiation, and initial...
Would surgical margins, evidence of angiolymphatic spread, number of lymph nodes removed during surgery inform your decision?
If not, how do you choose GVHD prophylaxis regimen? Is there a preference?
E.g. would you dose-reduce or continue at same dose?
Baseline ANC was in the normal range
How reliable is somatic testing to detect an underlying germline predisposition?
Is skin testing advised prior to trialing alternative?
iPET2 and iPET4 showed Deauville 5 response. CT biopsy after 4 cycles was negative. Patient is currently scheduled for 2 additional cycles of ABVD.
Ewing sarcoma of the right lung, status post bi-lobectomy and adjuvant VDC/IE, with recurrence 6 years in the right lung only. He has reached a cumula...
Do you ever add prophylactic Keppra (levetiracetam) for glioblastoma patients without a seizure history based on data such as this study (nature.com) ...
How does graft function play into your decision making? How do you utilize post allogeneic transplant chimerism in clinical practice? Do you obta...
Presuming strong indication for ASA - eg history of NSTEMI
In patients who continue to have insomnia despite diphenhydramine, benzos, and trazodone, are there other evidence based treatments that are helpful?
If so, what regimen do you utilize?
If serum markers were normal, how strongly do you consider 1 cycle of BEP for embryonal predominant pathology?
VIP can be considered, but given complex psychosocial issues and limited community cancer treatment resources, this question is being asked.
What is the impact among patients and providers?
Has your documentation been adjusted now that patients can readily review?
NCCN guidelines state check at baseline and then as clinically indicated. Some other sources state, can check prior to each cycle of BEP?
What ...
Does the degree of resectability affect your management?
Does treatment with B-cell depletion and/or negative anti-spike antibody status despite COVID mRNA vaccination influence your decision?
e.g. DITP from eptifibatide after a cardiac intervention
IVIG, TPO, or other agents?
Given persistent embryonal histology on RPLND, do you favor observation or TIP/VIP? What do you use to guide your decision?
How does your treatment approach vary depending on the underlying predisposition?
Given the POLARIX study data presented at ASH 2021, will this replace R-CHOP as the standard of care therapy in your practice? If not, how will y...
Would you offer indefinite anticoagulation if the event is unprovoked and the patient has low bleeding risk?
Also is there value in using voxelotor for the purpose of reducing hemolysis, and if so what parameters do you use to determine when to initiate voxel...
Is there a particular sequence you would adjust contributing antirejection or antimicrobial medications? Is the use of G-CSF appropriate and at what c...
Hydroxyurea is demonstrated to reduce complications and improve long-term outcomes in severe genotypes HbSS and sickle beta0 thalassemia. What clinica...
Are there other supportive care interventions that would otherwise be covered by hospice?
Provoked or unprovoked VTE: Do you use D-Dimer (or even repeat imaging to reassess residual clot) in any capacity to guide anticoagulation duration? E...
Have you used anticoagulants other than coumadin? Or is that the only appropriate agent given monitoring is based on PT/INR?
Do your recommendations differ between those who receive ABVD and escalated BEACOPP?
Do you recommend consultation with fertility specialists for all...
Especially with the current drug shortage of nelarabine.
While building a trusting patient-physician relationship, what therapies could be discussed that may be aligned with naturopathic medicine? (i.e. L-gl...
Does manipulation of blood products (leukoreduction, irradiated) affect your approach? There is growing evidence that routine premedication (at least ...
In particular, is there any data on the efficacy of Ipilimumab/Nivolumab?
While this is a known risk factor for venous [Meijers et al NEJM 2000] and potentially arterial [Yang et al, Am J Clin Pathol 2006] thrombosis, it is ...
Would this change with someone who has a history of thrombosis (e.g. DVT/PE, MI, CVA)?
Would this change with someone who is more fit vs more frail?
Results of AHOD1331 are not yet known, but adults have started using Brentuximab upfront for high risk patients
Such as patients who are frail, elderly, renally impaired?
Would you consider sirolimus over cyclosporine or tacrolimus for safer nephrotoxicity prof...
How often do you monitor ADAMTS-13 levels off therapy?
For example, do we prefer one regimen over the other in patients with a bleeding history or who have relapsed after a lengthy remission?
In follow up to @Jacqueline Casillas presentation at ASCO 2021 regarding models of survivorship care delivery for AYA patients.
If given both options, which donor would one prefer: haploidentical related donor or 7/8 mismatched unrelated donor using post transplant cyclophospha...
NCCN guideline V4.2021 DLBCL page BCEL-3 states stage I-II, bulky >= 7.5cm should be treated with 6 cycles of RCHOP, but most bone lymphoma studies...
Is there a role for empiric antibiotics if there is history of opportunistic infection?
Are there any effective non-pharm or pharm interventions?
Would you plan straight pediatric dosing using 2500 Units/m2 or a cap of 3750 Units as used in some adult ALL regimens due to excess liver/pancreas to...
s/p optimal debulking.
If this was an early-stage cancer would it change your adjuvant therapy recommendations?
Do you follow the 2019 EULAR Guidelines that SLE patients with asymptomatic, positive aPL should be on low-dose ASA?
Would you use ALK inhibitors such as crizotinib based on recent phase II data?
Are there any research efforts to combine ALK inhibitors with current ...
Do you always treat with the full 21-day treatment course, or can defibrotide be stopped if certain criteria are met sooner?
Do you prefer a cHL chemotherapy backbone or PMBL chemotherapy backbone?
While thrombophilia testing is not routinely recommended prior to starting OCPs, how about after the development of a VTE?
During the Stimate recall, how are we performing DDAVP challenges for newly diagnosed hemophilia A or von Willebrand disease?
Have the RAPID or CALGB 5064 studies changed your treatment approach?
Specifically, are there strategies you use to 1) empower patients to participate in decision-making and 2) reassure patients who may be skeptical?
Presented at ASH: FLIGHT trial
If standard of care BEP chemo, tandem transplant, and radiation to primary site have been done previously.
What is the lowest level you have seen with uncomplicated or complicated crises?
There are mixed recommendations about re-testing vs simply waiting for a quarantine period prior to resuming therapy.
Is there a preferred strategy of transfusional support versus reduced-dose anticoagulation during the duration of thrombocytopenia?
What if this was "triple-negative" antiphospholipid syndrome?
I have heard <20% MRD. What about proceeding if patient is hypoplastic after chemotherapy?
After optimizing symptoms and reversible factors, and attempting cognitive-behavioral interventions and exercise, do you recommend pharmacologic agent...
Presented with mass projecting into right/left anterior ethmoid complex
CT scans show omental and pelvic disease.
Would you consider “bridging” therapy with something like an HMA?
Is it at neutrophil recovery, at documentation of CR on bone marrow biopsy, or is there a different point in time?
Does acute leukemia sub-type affect your decision?
What are there most evidence-based options?
E.g. a patient with progression of their primary cancer but still is testing COVID19+ over a month after infection?
Are you placing more weight on patient risk factors such as age >65 or co-morbidities?
What advice do you give regarding dietary practices, feeding tubes / parenteral nutrition, and pharmacotherapy specifically for cachexia?
Should treatment be based on current histology (rhabdomyosarcoma) or origin (germ cell)?
What if the patient has a history of confirmed COVID-19 but has since recovered?
Discussion of treatment options for midline low-grade glioma causing life-altering symptoms in a pregnant patient to avoid teratogenicity.
At what age would you treat an early stage hodgkins lymphoma patient with ABVD + RT (adult treatment) vs OEPA x 2 or AV-PC x 3 (pediatric paradigm)?&n...
Do you limit it to post-pubertal patients? Do you offer it only if they will proceed with bone marrow transplantation after CAR-T?
GI work up negative. NGS cancer type and isochromosome 12p ordered and pending. Pathology at RPLND was negative for cancer.
There are conflicting reports of increased incidence of bleomycin-induced lung toxicity with G-CSF.
Obviously, patient and caregiver preferences are paramount. But, what factors do you consider? Does expanded hospice (e.g., Medicare Care Choices) inf...
Acknowledging that there is no time for good trials yet in this setting
How would you approach a patient who is receiving chemoRT but has confirmed COVID-19 with minor symptoms, as breaking treatment for 2 weeks quarantine...
-The data on induction for adult H&N ca has been mixed (excluded NPX) but recent data suggest a benefit for adult NPX.
-Given that this is standa...
How do you assess risk of tumor lysis syndrome, and is hydration sufficient or should hypouricemic agents be used as well?
In a patient s/p orchiectomy and with pelvic lymphadenopathy, would you consider lymph node biopsy to confirm involvement by non-seminomatous germ cel...
Is there a role for immunotherapy outside of trial setting?
Given the non-specific nature of AFP and its elevation in various benign conditions, is there an AFP cutoff level or change over time for which you wo...
Is any amount of teratoma or PNET an indication for surgery?
What dose do you recommend?
1735320947220901667316061150312097320733205908327206292122721386212951983529717853206961412037021051184982069228421943820502129491891619815196421929319591187661656816257164905634191001916714321720418999178361889416541188671808218549149081293918752186661867118588858093889789181441625118386183901737318352173331215417158117581809418053170881716517871105291773917556175819976163828196147891738514365173979747171031677716866121138610163151524166171618614994165041638013768162531523836811545015784161331190516042937723815679153821549315316155131573771651347911296154389536153551533310775152241211148731495714868147591467793761465214684137531424614408142511117114170138651383513845136871364012448131831352012999134211140812853109571281712802607412224125681253212566123121233112161123341225388071156711975117981190311797116321143811643115971157097591127611127111288125836410873108099286108551062510653968110511103251055210317104209049104089482983410302101798606101141001310023100399963997399239768988498449741403195639612949292639219922592078521919191688235892390118810868888178832877986408494844581148034797578507436769075727661752659444003739572797104676971869327116711471086941703470356893644369306768677868106718672967906165131939503764266220261036862
Papers discussed in this category
Gynecol Oncol, 2019 Aug 16
JAMA,
Cancer, 2004-08-15
Br. J. Haematol., 2003-11-01
Br. J. Haematol., 1998-08-01
Cancer, 1990-11-15
Radiother Oncol, 1990-01-01
Indian J Urol,
Medical and pediatric oncology, 1981
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016-07
Clinical breast cancer, 2003-02
Clin. Cancer Res.,
Fertil. Steril., 2013 Sep 05
The New England journal of medicine, 2020 Apr 22
J. Clin. Oncol., 2019 Sep 25
Lancet Oncol., 2020 Feb 14
Ann. Oncol., 2020 Mar 26
Chest, 1997-03
J. Clin. Oncol.,
Clin Genitourin Cancer, 2017 Sep 04
Eur. Urol., 2020 Jan 01
J. Clin. Oncol., 2019 Sep 10
Journal of the National Cancer Institute, 2005-09-21
Eur. J. Cancer,
Br. J. Cancer, 2007 Jan 30
American journal of hematology, 2018-08
Blood, 2019-04-04
Am. J. Hematol., 2019 Nov 19
J. Neurosurg., 2017 Mar 03
Acta Neurochir (Wien), 2019 Jan 29
J. Neurooncol., 2018 Apr 06
J. Clin. Oncol., 2020 May 20
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-04-10
Proceedings of the National Academy of Sciences of the United States of America, 2015-11-03
Oncologist, 2020 Mar 10
Semin Diagn Pathol, 2016 Dec 23
The New England journal of medicine, 2007-01-25
Haematologica, 2020
Nature, 2019-03
Blood, 2018 May 02
Leuk Lymphoma, 2019 Dec 26
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013-09-01
Journal of the National Cancer Institute, 2013-08-21
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2010-02
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2016-04
Blood, 2018 Jul 12
Ann. Intern. Med., 2019 Oct 15
Blood Transfus, 2018 Oct 24
J Thromb Haemost, 2018 May 08
Blood, 2015-10-29
The New England journal of medicine, 2017-02-02
Blood, 2009 Nov 10
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001-03-15
Clin Nutr, 2015 Aug 28
Clin Lymphoma Myeloma Leuk, 2017 Mar 07
American journal of hematology, 2011-10
The American journal of medicine, 2017-12
American journal of hematology, 2018-05
Am J Hematol, 2020 Jun 29
Am J Hematol, 2019 Sep
Am J Hematol, 2019 Sep
Am J Hematol, 2018 Jun
JAMA,
N Engl J Med,
The journal of allergy and clinical immunology. In practice, 2017
Archives of surgery (Chicago, Ill. : 1960), 2008-07
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018-01
Ann Surg,
N. Engl. J. Med., 2015-04-23
Blood, 2018 Sep 6
J Clin Oncol, 2017 Mar 14
Blood, 2020 Sep 23
The Lancet. Oncology, 2018-03
The Lancet. Oncology, 2019-06
J Hematol Oncol, 2016 Jun 03
The Lancet. Oncology, 2017-11
Blood, 2013-12-05
Blood Adv,
Blood,
Blood, 2013 Sep 19
The Lancet. Haematology, 2015-09
Haematologica, 2017-07
Thrombosis, 2013
Thrombosis journal, 2023 Oct 26
American journal of hematology, 2019-04
Cancer medicine, 2019-01
Journal of the National Cancer Institute, 1988-07-06
Annals of oncology : official journal of the European Society for Medical Oncology, 2015-02
Anticancer Drugs,
J Adolesc Young Adult Oncol, 2019 Nov 08
N. Engl. J. Med., 2018-01-25
Bone Marrow Transplant, 2019 Oct 01
Front Immunol, 2020 Apr 03
Blood, 2021 Mar 08
Gynecologic oncology, 2016-01
Gynecol Oncol, 2020 Jul 9
Gynecol Oncol, 2020 Jul 25
The New England journal of medicine, 2016-07-14
Practical radiation oncology, 2021 Sep-Oct
Palliative medicine, 2022 Mar 31
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023 Mar 28
J Clin Oncol, 2021 Apr 07
Ann Oncol, 2007 Nov 15
Leuk Lymphoma, 2019 Nov 04
Seminars in hematology, 2013-07
EMBO Mol Med, 2020 Apr 29
J Oncol, 2020 Jun 24
Pediatr Blood Cancer, 2019 Jul 24
J. Clin. Oncol., 2020 Feb 14
Cancer, 2020 May 19
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016-02-01
Cancer, 2020 Mar 15
J Clin Oncol, 2021 Apr 06
Ann Oncol, 2021 Mar 18
Clin Transl Oncol, 2020 Sep 17
J Assist Reprod Genet, 2020 Jun 02
Lancet Oncol, 2018 Sep 13
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013-02-20
Lancet (London, England), 2010-12-11
Blood, 2012 Apr 04
Clin Lymphoma Myeloma Leuk, 2019 Sep 30
Bone Marrow Transplant, 2018 Jun 08
The Lancet. Oncology, 2017-09
J Clin Oncol, 2020 Apr 10
Blood, 2016-07-14
Blood, 2016 Sep 26
Transfusion, 2020 Sep 24
Lancet Haematol,
British journal of haematology, 2014-06
International journal of radiation oncology, biology, physics, 2019-06-01
Annals of oncology : official journal of the European Society for Medical Oncology, 2007-04
Blood, 2018-07-05
Blood,
Blood,
J Clin Oncol, 2021 Jun 25
Journal of the National Cancer Institute, 2010-08-18
Blood, 2019-06-06
Eur J Haematol, 2021 Feb 17
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2011-10
Journal of oncology practice, 2019-01
Support Care Cancer, 2021 Aug 16
Arthritis Rheumatol, 2021 Apr 01
The New England journal of medicine, 1981-09-24
Ann Intern Med,
Cancer, 2011 Feb 01
Cancer Cell, 2020 Oct 08
J Gen Intern Med, 2021 Feb 02
JAMA Netw Open, 2020 Jun 01
Practical radiation oncology, 2019-03
Blood, 2008-02-15
Blood, 2016-07-28
Blood advances, 2016-12-27
The Lancet. Haematology, 2018-12
N Engl J Med,
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015-04
Pediatr Blood Cancer, 2019 Jul 31
American journal of hematology, 2020 Dec 08
Blood cancer journal, 2023 Oct 11
Journal of hospital medicine, 2018-08-01
Front Oncol, 2022 Mar 09
BMJ Support Palliat Care, 2022 Jul 08
Nutr Cancer, 2019 Oct 12
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016-03-01
Sci Rep, 2020 Jul 01
Neuro Oncol,
Annals of oncology : official journal of the European Society for Medical Oncology, 1993-11
Gastroenterology, 1993-06
Gastroenterology, 1991 Jul
Z Naturforsch C J Biosci, 2002 Mar-Apr
Immunopharmacol Immunotoxicol, 2003 Nov
Exp Toxicol Pathol, 2002 Feb
Biochem Biophys Res Commun, 1999 Sep 24
Ital J Gastroenterol Hepatol, 1998 Dec
Chem Biol Interact, 2001 Dec 21
Metal-based drugs, 2010
J Allergy Clin Immunol Pract, 2019 Feb 15
Pediatr Blood Cancer, 2021 Apr 12
The Lancet. Haematology, 2019-03
J Clin Oncol, 2021 Dec 02
Urology, 1982-09
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2009-03
Clin Infect Dis, 2005 Jan 21
Pediatr Transplant, 2014 Sep 08
J Clin Oncol, 2021 Apr 30
Pediatr Infect Dis J, 2014 Nov
Bone Marrow Transplant, 2006 Mar
Clinical cancer research : an official journal of the American Association for Cancer Research, 2008-01-15
Eur J Clin Pharmacol, 2001 Aug
JAMA Netw Open, 2021 Aug 02
Blood, 2006-05-01
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009-02-01
Blood, 2017-03-09
The Lancet. Oncology, 2015-10
N Engl J Med, 2013 Jul 11
Blood, 2012 Jun 19
Genetic epidemiology, 2016-09
American journal of hematology, 2019-03
Blood, 2021 Jan 07
Blood, 2019-04-11
N Engl J Med, 2022 Dec 11
European journal of cancer (Oxford, England : 1990), 2017-04
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006-02-01
Obstet Gynecol, 1998 Oct
Acta Oncol, 2019 Apr 08
Journal of neurosurgery, 2013-04
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019-05-01
Cochrane Database Syst Rev, 2020 Apr 28
J Clin Pharmacol, 2021 Jul 16
Eur Heart J, 2022 Nov 01
JACC CardioOncol, 2022 Dec 20
Pediatric blood & cancer, 2018-02
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014-11-01
Blood, 2018 Apr 5
Blood Adv, 2021 Aug 24
Blood, 2014 Apr 16
J Clin Oncol, 2018 Mar 02
N Engl J Med, 2009 Jan 07
Front Oncol, 2020 Jul 16
Leukemia, 2021 Jun 26
Haematologica, 2021 Nov 01
J Clin Oncol, 2019 Jun 10
Journal of palliative medicine, 2012-11
Nature reviews. Clinical oncology, 2016-03
Hered Cancer Clin Pract, 2021 Apr 01
The American journal of cardiology, 2018-12-01
Curr Oncol, 2021 Oct 13
Cardiooncology, 2019 Jan 29
Pediatr Transplant, 2021 Aug
Br J Haematol, 2023 May 2
Bone marrow transplantation, 2022 Dec 27
Eur Heart J, 2022 Jan 31
J Am Heart Assoc, 2020 Jan 21
Circulation, 2020 Jun 15
Journal of the National Cancer Institute, 2016-06
Pediatrics, 2014 Feb 02
N. Engl. J. Med.,
The Journal of urology, 2018-12
N. Engl. J. Med.,
Lancet Oncol., 2014 Feb 18
NEJM Evidence, 2022 Jun 1
Br J Cancer, 2014 Apr 15
Cancer, 2011-06-15
Eur J Cancer, 2017 Nov 28
N. Engl. J. Med., 2019 Sep 28
Lancet Oncol, 2021 Jan 18
J Clin Oncol, 2021 Apr 19
J Clin Oncol, 2003 Jul 01
JAMA, 2019 Apr 16
Head Neck, 2016 Mar 29
The Lancet. Oncology, 2017-05
Haematologica, 2019 Jan 03
JAMA Oncol,
Aging, 2009-12-31
Cell cycle (Georgetown, Tex.), 2010-11-15
BMC cancer, 2016-06-10
BMC Cancer, 2015 Oct 05
BMC Cancer, 2018 Apr 27
Int J Radiat Oncol Biol Phys, 2020 Jun 30
Contemporary clinical trials, 2017-02
Blood Adv,
Radiother Oncol, 2021 Dec 7
Int J Radiat Oncol Biol Phys, 2021 Dec 1
Int J Radiat Oncol Biol Phys, 2022 Dec 20
Transplant Cell Ther, 2022 Dec 30
Blood advances, 2020 Jul 28
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2022 Oct 26
Blood advances, 2020 Nov 24
Journal of the National Cancer Institute, 2018-01-01
JAMA oncology, 2021 May 01
Antioxidants & redox signaling, 2020 Aug 07
Journal of experimental & clinical cancer research : CR, 2020 Oct 07
BMJ (Clinical research ed.), 2000 Nov 04
J Hematol Oncol, 2022 Mar 26
Blood advances, 2022 May 10
International journal of radiation oncology, biology, physics, 2005-11-15
European journal of cancer (Oxford, England : 1990), 2007 Jan 30
JAMA oncology, 2018 Jan 01
Clin Cancer Res, 2021 Mar 25
Clinical cancer research : an official journal of the American Association for Cancer Research, 2021 Feb 25
Clinical cancer research : an official journal of the American Association for Cancer Research, 2021 May 14
European journal of cancer (Oxford, England : 1990), 2011 Jun 22
JCO oncology practice, 2023 Feb 10
The New England journal of medicine, 2007-07-26
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-04-01
Bone marrow transplantation, 2020 Dec 07
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020 Jul 16
The Lancet. Oncology, 2011 Dec 13
Transplantation reviews (Orlando, Fla.), 2021 Jun 24
American journal of hematology, 2016-09
Blood, 2017 Jun 13
N. Engl. J. Med.,
N Engl J Med,
Blood, 2009 Mar 10
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2023 May 01
The New England journal of medicine, 2023 Dec 12
The New England journal of medicine, 2016-04-07
N Engl J Med, 2023 Jun 04
Journal of oncology practice, 2018-09-04
Leukemia & lymphoma, 2022 Mar 15
Hematology. American Society of Hematology. Education Program, 2020 Dec 04
N Engl J Med, 2017 Jun 8
JAMA, 2023 Aug 8
Blood, 2017 Jan 31
The Lancet. Oncology, 2014 Mar 05
European journal of cancer (Oxford, England : 1990), 2019 Jan 25
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019-04-20
Blood, 2021 May 13
JACC. Heart failure, 2022 Jun 08
Cardio-oncology (London, England), 2021 Sep 27
JACC. CardioOncology, 2023 Jun 20
Medicina oral, patologia oral y cirugia bucal, 2008 Oct 01
Blood, 2023 Mar 23
Neuro-oncology advances, 2021 Apr 19
The New England journal of medicine, 2008-03-27
The New England journal of medicine, 2020 Jun 25
Frontiers in genetics, 2022 Aug 26
Chest, 2012-02
N Engl J Med, 2020 Mar 29
Chest, 2021 Oct 08
Thrombosis journal, 2017 Oct 03
Lupus, 2014 Jul 30
MMWR. Morbidity and mortality weekly report, 2024 Sep 12
Journal of the Endocrine Society, 2022 Dec 02
Diagnostics (Basel, Switzerland), 2021 Apr 20
Blood, 2022 Jun 16
Annals of the rheumatic diseases, 2023 Mar 31
Blood, 2016-03-31
Bone marrow transplantation, 2016-07
Bone marrow transplantation, 2018-02
British journal of haematology, 2020 Mar 04
Blood advances, 2022 Jan 11
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2020 Jan-Dec
Bone marrow transplantation, 2022 Dec 23
American journal of clinical oncology, 2021 Aug 01
Annals of gastroenterology, 2022 Jun 02
Melanoma research, 2023 Mar 27
Br J Haematol, 2023 Dec 10
Blood advances, 2024 Jan 09
Blood advances, 2023 Apr 11
Clinical cancer research : an official journal of the American Association for Cancer Research, 2024 Jan 05
Int J Radiat Oncol Biol Phys, 2006 Dec 1
Int J Radiat Oncol Biol Phys, 2019 Oct 10
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2021 May 05
International journal of radiation oncology, biology, physics, 2013-03-01
International journal of radiation oncology, biology, physics, 2020 Jan 24
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2001 Mar
Cancer research and treatment, 2006 Dec 31
European journal of haematology, 2023 Aug 27